Merck & Co. (MRK) to Slash 120 Staffers at Newly-Acquired Cubist (MRK) Drug Discovery Unit
Shire (SHPGY) Will Hand Pink Slips to 600 Employees in Pennsylvania
AbbVie (ABBV) Outbids Johnson & Johnson (JNJ) and Lands Pharmacyclics (PCYC) for $21 Billion
Mallinckrodt (MNK) Forks Out $2.3 Billion for Respiratory Drug and Device Maker Ikaria
Bristol-Myers Squibb (BMY) Grabs Record Fast Approval for Opdivo
Backed By Investors Like Ex-Genzyme (GENZ) CEO, Aura Biosciences Locks In $21 Million
Novartis AG (NVS) Unloads RNAi Portfolio to Arrowhead Research Corporation (ARWR) for $35 Million
EXCLUSIVE: Experimental Cancer Drug From Oncoceutics Could Be Fast-Tracked, Says Exec
Orexigen (OREX)'s Failure to Keep a Lid on it Prompts the FDA to Force a Second Study
Bristol-Myers Squibb (BMY) Bets $975 Million on Bavarian Nordic (BAVA.CO)'s Prostate Cancer Vaccine
After Turning Down Sanofi (SAN.PA) Gig, Takeda (TKPYY) COO Gets Promoted to CEO
Novartis AG (NVS) Will Move Past Scandal While Hunting for More M&A in the $2-5 Billion Range, Says CEO
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst
Baxter International (BAX) Snaps Up German Biopharma for $225 Million
Backed By a Genentech (RHHBY) Alum, NGM Looks Like it Could be the Next Biotech IPO
Malin, Formed by Ex-Elan (ELN) Execs, Eye Up to $365 Million in Biotech IPO
Valeant (VRX) Starts Chopping Dendreon (DNDN) Employees
Genentech (RHHBY)'s Controversial Distribution Move Deemed a Failure: Survey
See All News >
Orexigen (OREX)'s Failure to Keep a Lid on it Prompts the FDA to Force a Second Study
Bristol-Myers Squibb (BMY) Bets $975 Million on Bavarian Nordic (BAVA.CO)'s Prostate Cancer Vaccine
After Turning Down Sanofi (SAN.PA) Gig, Takeda (TKPYY) COO Gets Promoted to CEO
Novartis AG (NVS) Will Move Past Scandal While Hunting for More M&A in the $2-5 Billion Range, Says CEO
Baxter International (BAX) Snaps Up German Biopharma for $225 Million
Backed By a Genentech (RHHBY) Alum, NGM Looks Like it Could be the Next Biotech IPO
Malin, Formed by Ex-Elan (ELN) Execs, Eye Up to $365 Million in Biotech IPO
Valeant (VRX) Starts Chopping Dendreon (DNDN) Employees
Genentech (RHHBY)'s Controversial Distribution Move Deemed a Failure: Survey
A Peek Inside Ex-Dendreon (DNDN) CEO, Amgen (AMGN) Scientists' New Startup Alpine Immune Sciences
CALBIO15: Johnson & Johnson (JNJ) Unveils New Innovation Center, Looks to Spark Creative Revolution in the Bay: Exec
Check This Out: The $500 Check That Helped Launch Genentech (RHHBY)
Finally! Average Penis Size For Men Revealed, King's College London Study
With Two Ex-Elan (ELN) Execs at the Helm, Bay Area's Serenus Nabs $43 Million
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib
Poll Result for Best Hair In BioPharma Crown Receptos (RCPT)'s Hasnain King
Teva (TEVA) Sells Plant, 25 Drugs to G&W Laboratories; 280 Jobs Salvaged
Vertex (VRTX) Terminates Leases on Three Properties in Cambridge, Massachusetts
See All News >
//-->